Prostate Specific Antigen Decline after Antiandrogen Withdrawal: the Flutamide Withdrawal Syndrome-Reference-Cited by-同舟云学术

Prostate Specific Antigen Decline after Antiandrogen Withdrawal: the Flutamide Withdrawal Syndrome

Published:1993-03 Issue:3 Volume:149 Page:607-609
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Kevin Kelly Wm.¹,Scher Howard I.¹

Affiliation:

1. From the Genitourinary Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center and Department of Medicine, Cornell University Medical College, New York, New York

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference22 articles.

1. Clinical usefulness of serum prostate specific antigen after hormonal therapy of metastatic prostate cancer;Miller;J. Urol.,1992

2. Kelly, W. K., Scher, H. I., Mazumdar, M. and Vlamis, V.: Prostate specific antigen (PSA) as a measure of disease outcome in hormone refractory stage D2 prostate cancer. J. Clin. Oncol., in press.

3. Effect of suramin on human prostate cancer cells in vitro;La Rocca;J. Urol.,1991

4. Trimetrexate in prostatic cancer: preliminary observations on the use of prostate-specific antigen and acid phosphatase as a marker in measurable hormone-refractory disease;Scher;J. Clin. Oncol.,1990

5. Spontaneous circadian fluctuations of prostatic specific antigen and prostatic acid phosphatase serum activities in patients with prostatic cancer;Mannini;Urol. Res.,1988

Cited by 254 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel treatment strategies to overcome resistance in prostate cancer;Therapy Resistance in Prostate Cancer;2024

2. Darolutamide (Nubeqa); An Androgen Receptor Antagonist for Treating Nonmetastatic, Castration‐Resistant Prostate Cancer;Current Drug Synthesis;2022-09-22

3. Nonmetastatic Castration-Resistant Prostate Cancer: Current Challenges and Trends;Clinical Drug Investigation;2022-07-13

4. Comprehensive Characterization of Androgen-Responsive circRNAs in Prostate Cancer;Life;2021-10-15

5. Treatment and resistance mechanisms in castration-resistant prostate cancer: new implications for clinical decision making?;Expert Review of Anticancer Therapy;2020-11-16